Medical devices, healthcare technology and the business of care
510(k) clearance · K261274

EchoTip Ultra Endobronchial HD Ultrasound Biopsy Needle for Fujifilm Scopes; EchoTip ProCore Endobronchial HD Ultrasound Biopsy Needle for Fujifilm Scopes

Cook Ireland, Ltd. · Decision date Jul 24, 2026

FDA DECISIONK261274

What did the FDA decide?

FDA records K261274 as a 510(k) premarket notification, with a decision dated Jul 24, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Ear, Nose, Throat
Decision date
Jul 24, 2026

FDA source record

Regulatory record facts

Identifier
K261274
Regulatory pathway
510(k) premarket notification
Product code
KTI
Decision code
SESE
Decision date
Jul 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Bronchoscope Accessory.

Product code
KTI
FDA device class
2

FDA decision timeline

  1. K261274 received

    Application receipt date recorded by FDA.

  2. K261274 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KTI

Product / regulatory recordCompanyPathwayDecision dateSource
Finemedix Co., Ltd.510(k) clearanceApr 16, 2026FDA
Free Flow Medical, Inc.510(k) clearanceMar 12, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cook Ireland, Ltd.

Headquarters
Not reported
Brand website
cookmedical.com
FDA applicant address
Limerick

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records